Regression of Hamstring Flexibility and Performance in Children With Duchenne Muscular Dystrophy
NCT ID: NCT03589612
Last Updated: 2019-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2018-03-08
2019-01-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation Of Factors Affecting Hand Functions in Nonambulatory Patients With Duchenne Muscular Dystrophy
NCT03521271
Motor Imagery on Children With DMD on Gait and Balance Functions
NCT05601986
Postural and Anthropometric Properties of Foot and Ankle of Patients With DMD
NCT05436210
Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption
NCT03529240
Upper Extremity Muscle Strength, Balance and Functional Skills in DMD
NCT06379906
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being in the ambulatory period and climbing four steps independently,
* to be Level 1 and Level 2 according to Brooke Lower Functional Classification Test
* To be able to cooperate
* No any severe contracture in the lower limbs which may prevent assessments,
Exclusion Criteria
5 Years
14 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lütfiye AKKURT, PT
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Güllü Aydın, Msc.
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
Numan Bulut, Msc
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
İpek Gürbüz, Assoc.Prof.
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
Ayşe Karaduman, Prof.
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
Oznur Yılmaz
Role: STUDY_DIRECTOR
Hacettepe University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacettepe University
Ankara, Sıhhiye, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GO 16/740-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.